Skip to main content
. 2018 Dec 14;19(2):1203–1209. doi: 10.3892/mmr.2018.9765

Figure 5.

Figure 5.

Metformin attenuates 5-FU resistance of HCT116 sphere cells. (A) Cell viabilities of HCT116 colorectal cancer cells treated with 5-FU and of HCT116 colorectal cancer sphere cells treated with 5-FU with or without metformin treatment, were determined using a Cell Counting Kit-8 assay. (B) Expression levels of apoptosis executors (cleaved caspase-3 and cleaved PARP) were detected in the cells in the different treatment groups. Data are presented as the mean ± standard deviation; **P<0.01 vs. control. 5-FU, 5-fluorouracil; PARP, poly(ADP-ribose) polymerase.